Skip to content

The influence of COVID-19 pandemic on cardiovascular patients

The influence of COVID-19 pandemic on cardiovascular patients

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2000032632
Enrollment
Unknown
Registered
2020-05-04
Start date
2020-03-20
Completion date
Unknown
Last updated
2020-05-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cardiovascular disease

Interventions

Case series:Nil

Sponsors

First Affiliated Hospital of Xinjiang Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 90 Years

Inclusion criteria

Inclusion criteria: Adult patients with acute coronary syndrome (ACS) attended the Department of Cardiology, the First Affiliated Hospital of Xinjiang Medical University during the period of January 2019 to December 2019 and underwent percutaneous coronary intervention (PCI) were consecutively recruited. Subject should meet the following inclusion criteria:1 All patients received optimal medical therapy at least 3 months after discharge, including aspirin, clopidogrel/ ticagrelor, statin, Beta-blocker, and ACEI or ARB; 2 Before the outbreak, outpatient visit including physical examination, laboratory test and echocardiography was made in our hospital; 3 After removing the activity restriction, patients received outpatient follow-up and agreed to participate in the study.

Exclusion criteria

Exclusion criteria: The patient had communication disorder and could not complete the questionnaire.

Design outcomes

Primary

MeasureTime frame
LDL-C;HDL-C;Exercise;

Countries

China

Contacts

Public ContactZhen-Yan Fu

The First Affiliated Hospital of Xinjiang Medical University

fuzhenyan316@126.com+86 13639903192

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026